Pregled bibliografske jedinice broj: 1180994
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis.
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis. // Sarcoidosis, vasculitis and diffuse lung disease, 36 (2019), 4; 274-284 doi:10.36141/svdld.v36i4.7612 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1180994 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum cytokines and their predictive value in
pulmonary involvement
of systemic sclerosis.
Autori
Becker MO ; Radic M ; Schmidt K ; Huscher D ; Riedlinger A ; Michelfelder M ; Meisel C ; Ewert R ; Burmester GR ; Riemekasten G.
Izvornik
Sarcoidosis, vasculitis and diffuse lung disease (2532-179X) 36
(2019), 4;
274-284
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
systemic sclerosis, cytokines, chemokines, lung involvement, survival
Sažetak
Objective: To identify serum cytokines which predict mortality and/or disease progression in patients with systemic sclerosis, especially with pulmonary involvement. Methods: Serum cytokines (IL-6, IL-7, IL- 8, IL-10, CCL2, CCL4, TGF-β, TNF- α) were measured in 125 SSc patients, who were recruited and observed in our outpatient clinic. Of these, 60 had pulmonary involvement, classified as either interstitial lung disease (ILD, 43 patients), pulmonary arterial hypertension (PAH, 7 patients) or pulmonary hypertension and ILD (PH- ILD, 10 patients). The association of serum cytokines with clinical features was analysed and their correlation with BAL cytokines measured in a subset of SSc patients with ILD. Results: Serum cytokines were detected at dif- ferent levels: high (TGF-β, median 287.5 pg/ml ; CCL2, median 89.7 pg/ml ; CCL4, median 104.2 pg/ml), low (IL-6, median 3.2 pg/ml ; IL-7 median 2.3 pg/ml ; IL-8, median 5.2 pg/ml ; TNF-α, median 0 pg/ml but with a bimodal distribution) and very low (IL-10, median 0.4 pg/ml). IL-6 and IL-7 were predictive for death in a Cox regression analysis in all SSc patients as well as in all patients with pulmonary involvement ; IL-6 was predictive for mortality in SSc- ILD patients. In a multivariate analysis, cytokine levels could also predict a change in lung function, e.g. IL-7 was a predictor for a decline of diffusion capacity (DLCO) by 20 or 30% in ILD patients. In a subset of ILD patients, serum cytokines were compared to BAL cytokines, but revealed only few correlations. Conclusion: In conclusion, the analysis of serum cytokines implicates a role as biomarkers, distinct from BAL.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI